Fig. 1From: Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivationKaplan Meier survival curve of biochemical free survival for intermediate and high risk patients. Median survival for high risk patients was 10.3 yrs. Median survival was unreached. For intermediate risk patientsBack to article page